Publication | Closed Access

Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy

Palliative CareGeriatric OncologyOncologySevere Adverse EventsElderly PatientsCancer ManagementBronchial NeoplasmCancer TreatmentSecond-line TherapyMedicineRadiation OncologyLung Cancer